1. Home
  2. RWT vs AKBA Comparison

RWT vs AKBA Comparison

Compare RWT & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$5.82

Market Cap

715.8M

Sector

Real Estate

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.37

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWT
AKBA
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
715.8M
729.1M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
RWT
AKBA
Price
$5.82
$1.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$6.86
$6.25
AVG Volume (30 Days)
1.4M
3.0M
Earning Date
02-12-2026
03-12-2026
Dividend Yield
12.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$120,897,000.00
$225,071,000.00
Revenue This Year
N/A
$52.38
Revenue Next Year
$46.22
$22.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.49
52 Week Low
$4.68
$1.30
52 Week High
$6.73
$4.08

Technical Indicators

Market Signals
Indicator
RWT
AKBA
Relative Strength Index (RSI) 56.78 38.09
Support Level $5.63 $1.30
Resistance Level $6.00 $1.41
Average True Range (ATR) 0.16 0.08
MACD 0.01 0.00
Stochastic Oscillator 72.79 24.48

Price Performance

Historical Comparison
RWT
AKBA

About RWT Redwood Trust Inc.

Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: